INCYTE Corporation (INCY)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
Herve Hoppenot
Employees:
2320
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
3024986700
| Date | Ratio |
|---|---|
| 1997-11-10 | 2.0000 |
| 2000-09-01 | 2.0000 |
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD) It also develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|